A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1)

References

• Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18–29.
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Bonfanti G, Morabito A, Bufalino R, Menotti V, Andreola S, A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 1986;162:229–34.
   PubMedGoogle Scholar
• Adachi Y, Mori M, Maehara Y, Sugimachi K. Dukes's classification: a valid prognostic indicator for gastric cancer. Gut 1994;35:1368–71.
   PubMed Web of Science ®Google Scholar
• Maruyama K. The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses. Scand J Gastroenterol 1987;22:63–8.
   Web of Science ®Google Scholar
• Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 2001;4:113–21.
   PubMedGoogle Scholar
• Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression of NDRG1, a differentiation related gene, in human tissues. Histochem Cell Biol 2002;118:399–408.
   PubMed Web of Science ®Google Scholar
• Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T. Characterization of the human NDRG gene family:a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 2001;73:86–97.
   PubMed Web of Science ®Google Scholar
• Park H, Adams MA, Lachat P, Bosman F, Pang SC, Graham CH. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 2000;276:321–8.
   PubMedGoogle Scholar
• Kurdistani SK, Arizti P, Reimer CL, Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 1998;58:4439–44.
   PubMed Web of Science ®Google Scholar
• Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 1999;59:1966–72.
   PubMedGoogle Scholar
• Shimono A, Okuda T, Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 1999;83:39–52.
   PubMed Web of Science ®Google Scholar
• Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced overexpression of an HIF-1/hypoxiarelated protein in cancer cells. Environ Health Perspect 2002;110:783–8.
   PubMedGoogle Scholar
• Gómez-Casero E, Navarro M, Rodríguez-Puebla ML, Larcher F, Paramio JM, Conti CJ, Jorcano JL. Regulation of the differentiation-related gene drg-1 during mouse skin carcinogenesis. Mol Carcinog 2001;32:100–109.
   PubMedGoogle Scholar
• Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 2003;63:1731–6.
   PubMedGoogle Scholar
• Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation - related, putative metastatic suppressor gene in human colon cancer. Cancer Res 2000;60:749–55.
   PubMedGoogle Scholar
• Wang Z, Wang F, Wang WQ, Gao Q, Wei WL, Yang Y, Wang GY. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol 2004;10:550–4.
   PubMedGoogle Scholar
• Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 2002;118:399–408.
   PubMed Web of Science ®Google Scholar
• Arao T, Yanagihara K, Takigahira M, Takeda M, Koizumi F, Shiratori Y, Nishio K. ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer 2006;118:483–89.
   PubMed Web of Science ®Google Scholar
• Wang SN, Yeh YT, Yang SF, Chai CY, Lee KT. Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol 2006;59:930–4.
   PubMedGoogle Scholar
• Tomlinson IP, Bodmer WF. Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci USA 1995;92:11130–4.
   PubMedGoogle Scholar
• Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 1997;94:952–5.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159–70.
   PubMed Web of Science ®Google Scholar
• Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003;9:2202–6.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 2004;23:5675–81.
   PubMed Web of Science ®Google Scholar
• Shah MA, Kemeny N, Hummer A, Drobnjak M, Motwani M, Cordon-Cardo C, Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin Cancer Res 2005;11:3296–302.
   PubMedGoogle Scholar
• van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997;77:85–92.
   PubMedGoogle Scholar
• Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 2006;66:6233–42.
   PubMedGoogle Scholar
• Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 2004;64:7655–60.
   PubMed Web of Science ®Google Scholar
• Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 2004;279:48930–40.
   PubMedGoogle Scholar
• Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005;24:8277–90.
   PubMed Web of Science ®Google Scholar
• Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 2006;66:6233–42.
   PubMedGoogle Scholar
• Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 2006;66:11983–90.
   PubMedGoogle Scholar
• Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 2004;5:27.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang F, Wang WQ, Gao Q, Wei WL, Yang Y, Wang GY. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol 2004;10:550–4.
   PubMedGoogle Scholar
• Yan X, Chua MS, Sun H, So S. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett 2008;262:133–42.
   PubMedGoogle Scholar
• Sutherland RM. Tumor hypoxia and gene expression implications for malignant progression and therapy. Acta Oncol 1998;37:567–74.
   PubMed Web of Science ®Google Scholar
• Sprague LD, Mengele K, Schilling D, Geurts-Moespot A, Sweep FC, Stadler P, Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells. Oncology 2006;71:282–91.
   PubMedGoogle Scholar
• Calzada MJ, del Peso L. Hypoxia-inducible factors and cancer. Clin Transl Oncol 2007;9:278–89.
   PubMedGoogle Scholar